Irrimax Corporation, parent company to Innovation Technologies, Inc., holds patents for low-concentration CHG technology. Their flagship product, Irrisept, is a jet lavage containing low-concentration CHG in sterile water for irrigation. Irrimax's team of experts in product development, clinical research, manufacturing, and distribution are dedicated to improving patient outcomes and reducing healthcare costs through the development of medical products primarily for wound irrigation, cleansing, and debridement. Their products are designed to loosen and remove debris without harming underlying tissue during application to prevent infections.